Editor’s highlights from the Journal of Comparative Effectiveness Research – April 2023

Written by Laura Dormer, Editor

In this monthly column, I share some of my highlights from the latest issues of the Journal of Comparative Effectiveness Research, partner journal of The Evidence Base.


I’m pleased to share with you my highlights from the April issue (Volume 12, Issue 4) of the Journal of Comparative Effectiveness Research (JCER), including articles on the journal’s 2022 top content, patient experience in psoriasis and collaboration on real-world evidence generation across Europe.


Journal of Comparative Effectiveness Research: 2022 year in review

It is always interesting to look back at the articles our readers have been reading the most, and in the Foreword to this issue I shine the spotlight on some of the papers that most drew our readers’ attention throughout 2022, as well as discussing some things to watch out for throughout this year, including Peek Behind the Paper interviews on The Evidence Base.

Read the full article here


A plain language summary of what freedom from disease means to people with psoriasis according to doctors, nurses, and people with psoriasis

In JCER’s latest Plain Language Summary of Publication article, the authors van Ee et al. (Psoriasispatiënten Nederland (PN), The Netherlands) present findings from recent research involving people with psoriasis, based on an article originally published in the Journal of the European Academy of Dermatology and Venereology. Current psoriasis assessment tools used by healthcare professionals do not capture the complete experience of patients, and this study looked at what freedom from disease means to people with psoriasis according to doctors, nurses and people with psoriasis.

Read the full article here


Guidance on using real-world evidence from Western Europe in Central and Eastern European health policy decision making

In January 2025, the HTA Regulation on joint clinical assessments will take effect. However, barriers remain preventing Central and Eastern European countries from using Western European real-world evidence for healthcare decision making. In their Research Article, Németh et al. (Syreon Research Institute, Hungary) propose solutions to overcome these barriers.

Read the full article here


I hope our readers find the above, and the rest of the April issue interesting and useful. JCER welcomes presubmission enquiries, so do get in touch if you are interested in contributing to a future issue.